FEG
AMED

Financial Enhancement Group’s Amedisys AMED Stock Holding History

Financial Enhancement Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-911
Closed -$167K – 243
2020
Q1 		$167K Buy
911
+36
+4% +$6.41K 0.05% 94
2019
Q4 		$146K Sell
875
-6
-0.7% -$892 0.04% 88
2019
Q3 		$115K Buy
881
+26
+3% +$3.38K 0.03% 93
2019
Q2 		$104K Buy
855
+129
+18% +$15.3K 0.03% 104
2019
Q1 		$89K Buy
+726
New +$91.1K 0.03% 121

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Financial Enhancement Group's AMED Position: Q2 2020 in Review

Financial Enhancement Group sold out of Amedisys (AMED) in Q2 2020, closing a stake of 911 shares — an estimated $167K sold.

Financial Enhancement Group first reported a position in AMED in Q1 2019 and held it in 5 quarters. The position peaked at $167K in Q1 2020. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Financial Enhancement Group reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Financial Enhancement Group sold 911 Amedisys shares in Q2 2020, an estimated $167K.
  • Financial Enhancement Group first reported a position in Amedisys in Q1 2019 and held it in 5 quarters.
  • Financial Enhancement Group's Amedisys position peaked at $167K in Q1 2020.
  • 354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Financial Enhancement Group's 13F filing for Q2 2020, filed 14 Aug 2020.